Tuesday, May 13, 2014

Global Muckle-Wells Syndrome Market - Industry Analysis, size, share, Growth, Trends And Forecast, 2013 - 2019

Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Due to interaction of IL1B and skin receptors, the inflammation occurs, which leads to fever and rashes. The common symptoms include fevers, chills, deafness, arthritis, and recurrent urticaria.The episode of MWS usually lasts for around 48 hours. The disease belongs to a family of cryopyrin- associated periodic syndromes (CAPS), including 2 other diseases, caused by mutation of CIAS1 gene.

Muckle-Wells Syndrome can be diagnosed with the help of study of patient’s symptoms and medical evaluation. In addition, gene testing and NLRP3 mutation study also helps in diagnosis of the disease. Owing to extensive growth in genetic engineering, the market is expected to grow duringthe forecast period 2013 to 2019. The major treatments for MWS includes Rilonacept (for CAPS treatment), anakinra (IL-1 receptor antagonist) and Canakinumab, a monoclonal antibody. In addition to the existing treatments, some new treatments are under pipeline studies.

The market of Muckle-Wells Syndrome is driven by factors such as, extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Considering the growth perspective, many pharmaceutical and biotechnological leaders are engaged in the development of medications and treatments for this disease. However, low epidemiology, lack of awareness and high cost of R&D and treatment are some of the restraints, expected to impose a threat to the growth of the market.
Some of the major players engaged in development and commercialization of treatments for Muckle-Wells Syndrome includes Novartis AG, Istituto Giannina Gaslini, Regeneron Pharmaceuticals, Inc. and Charite-Universitatsmedizin Berlin amongst others. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·         It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse Market Researche Report:-


Post a Comment